Last Price$4.75NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/30/22

Today's Change-0.30(5.94%)
Bid (Size)$2.39 (1)
Ask (Size)$5.75 (2)
Day Low / High$4.71 - 4.93
Volume160.5 K

View Medical Specialties IndustryPeer Comparison as of 06/30/2022


AVITA Medical Inc ( NASDAQ )

Price: $4.75
Change: -0.30 (5.94%)
Volume: 160.5 K
4:00PM ET 6/30/2022

Enochian Biosciences Inc ( NASDAQ )

Price: $1.93
Change: -0.44 (18.57%)
Volume: 1.2 M
4:00PM ET 6/30/2022

AquaBounty Technologies Inc ( NASDAQ )

Price: $1.71
Change: -0.01 (0.58%)
Volume: 523.8 K
4:00PM ET 6/30/2022

DarioHealth Corp ( NASDAQ )

Price: $6.14
Change: +0.61 (11.03%)
Volume: 421.0 K
4:00PM ET 6/30/2022

Armata Pharmaceuticals Inc ( NYSE MKT LLC )

Price: $3.89
Change: +0.23 (6.28%)
Volume: 787.00
8:00PM ET 6/30/2022

Read more news Recent News

--Piper Sandler Adjusts Avita Medical's Price Target to $15 From $23, Reiterates Overweight Rating
10:55AM ET 3/01/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Avita Medical Says FDA Approves New Recell Cell Harvesting Device
4:16PM ET 2/17/2022 MT Newswires

Avita Medical (RCEL) said Thursday the US Food and Drug Administration has approved the premarket approval application supplement for the company's new...

Avita Medical Completes Enrollment in Soft-Tissue Reconstruction Study
5:00AM ET 1/07/2022 MT Newswires

Avita Medical (RCEL) said Thursday it has completed enrollment for the pivotal trial of the Recell System for soft-tissue reconstruction. Topline data...

Insider Sell: Avita Medical
4:47PM ET 9/07/2021 MT Newswires

Michael S Perry, Director, Chief Executive Officer, on September 01, 2021, sold 11,220 shares in Avita Medical (RCEL) for $232,030. Following the Form 4...

Company Profile

Business DescriptionAVITA Medical, Inc. through its subsidiaries, engages in the development and commercialization of technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product RECELL system is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company is headquartered in Valencia, CA. View company web site for more details
Address28159 Avenue Stanford
Valencia, California 91355
Number of Employees55
Recent SEC Filing06/02/20224
Chief Executive Officer & Executive DirectorMichael S. Perry
Chief Operating OfficerKathy McGee
Chief Financial OfficerMichael B. Holder
Chief Technology OfficerAndrew Quick

Company Highlights

Price Open$4.92
Previous Close$5.05
52 Week Range$4.57 - 21.21
Market Capitalization$118.5 M
Shares Outstanding25.0 M
SectorHealth Technology
IndustryMedical Specialties
Next Earnings Announcement08/25/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.17
Beta vs. S&P 500N/A
Revenue$1.3 M
Net Profit Margin-85.43%
Return on Equity-26.23%

Analyst Ratings as of 05/28/2022

Consensus RecommendationConsensus Icon
Powered by Factset